NEW YORK (AVAFIN) -- Eli Lilly & options contracts experienced a new 90-day record for call contracts where a total
of 504,000 call contracts were traded in the busy trading session. The contract spread
yielded a 0.01 put/call ratio where 80.7 call contracts were traded for each put contract.
Unusual volume provides reliable clues that the stock is expected to make a move. Investors
can use the put/call ratio statistics to measure trader sentiment. A high put/call ratio
suggests that the overall investment sentiment is bearish and that investors expect the
underlying stock to decrease in value. Conversely, a low put/call ratio implies that
investor sentiment is bullish based on the large amount of call options.
Lilly is focusing its development efforts on several unmet medical indications in neurology and oncology. The strategy should improve the success rate at the Food and Drug Administration, which has become exceedingly risk-sensitive to new drugs in well-treated areas such as cardiology.
Additionaly, Lilly's strong entrenchment in the diabetes industry should well position the company to expand into the fast-growing emerging markets, which are showing rapid growth rates in diabetes.
Shares of LLY opened today at $47.50 and settled the day up $0.83 to $48.30
during the session. The day's trading range is between $47.39 and $48.64 respectively.
Within the last month, shares of LLY have gained 12.38% of their value.
On the volume side, 7M shares were traded which is less
than the average volume of 8M shares. Eli Lilly & is trading below the 50 day
moving average and higher than the 200 day moving average. The stock's 52 week low is $35.46 and 52 week high is $53.99. The stock has a P/E ratio of 12.88 and a dividend yield of 3.10%.